Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
Authors:
- T TerasakiTTT Terasaki
- M NakamuraMNM Nakamura
- O NagataONO Nagata
- H KatoHKH Kato
- A TsujiATA Tsuji
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 16 (6) , 865-874
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR CEFAZOLIN IN RABBITS AND ITS PRELIMINARY EXTRAPOLATION TO MANDrug Metabolism and Disposition, 1985
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- Physiologically Based Pharmacokinetic Model for β-Lactam Antibiotics I: Tissue Distribution and Elimanation RatesJournal of Pharmaceutical Sciences, 1983
- In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acidAntimicrobial Agents and Chemotherapy, 1983
- In vitro and in vivo activity of DL-8280, a new oxazine derivativeAntimicrobial Agents and Chemotherapy, 1982
- Absorption, excretion, and metabolism of a new antibacterial agent, nalidixic acidToxicology and Applied Pharmacology, 1964